Bacillus Calmette - Guerin ( BCG ) for Urothelial Carcinoma of the Bladder

Timothy P. Kresowik; Thomas S. Griffith

doi:10.1002/9780470626528.ch3

Bacillus Calmette - Guerin ( BCG ) for Urothelial Carcinoma of the Bladder

Timothy P. Kresowik, Thomas S. Griffith

Urology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Original language	English (US)
Title of host publication	Emerging Cancer Therapy
Subtitle of host publication	Microbial Approaches and Biotechnological Tools
Publisher	John Wiley and Sons
Pages	49-70
Number of pages	22
ISBN (Print)	9780470444672
DOIs	https://doi.org/10.1002/9780470626528.ch3
State	Published - Aug 18 2010

Keywords

BCG development landmarks-immunotherapeutic agents for bladder cancer
Bacillus Calmette-Guerin (BCG) - for urothelial carcinoma of bladder
Genetic determinants of BCG response

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1002/9780470626528.ch3

Find It

Find It at U of M Libraries

Cite this

@inbook{4dda885f9e764177a815178a5c8e91fd,

title = "Bacillus Calmette - Guerin ( BCG ) for Urothelial Carcinoma of the Bladder",

keywords = "BCG development landmarks-immunotherapeutic agents for bladder cancer, Bacillus Calmette-Guerin (BCG) - for urothelial carcinoma of bladder, Genetic determinants of BCG response",

author = "Kresowik, {Timothy P.} and Griffith, {Thomas S.}",

year = "2010",

month = aug,

day = "18",

doi = "10.1002/9780470626528.ch3",

language = "English (US)",

isbn = "9780470444672",

pages = "49--70",

booktitle = "Emerging Cancer Therapy",

publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Bacillus Calmette - Guerin ( BCG ) for Urothelial Carcinoma of the Bladder

AU - Kresowik, Timothy P.

AU - Griffith, Thomas S.

PY - 2010/8/18

Y1 - 2010/8/18

KW - BCG development landmarks-immunotherapeutic agents for bladder cancer

KW - Bacillus Calmette-Guerin (BCG) - for urothelial carcinoma of bladder

KW - Genetic determinants of BCG response

UR - http://www.scopus.com/inward/record.url?scp=84886855216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886855216&partnerID=8YFLogxK

U2 - 10.1002/9780470626528.ch3

DO - 10.1002/9780470626528.ch3

M3 - Chapter

AN - SCOPUS:84886855216

SN - 9780470444672

SP - 49

EP - 70

BT - Emerging Cancer Therapy

PB - John Wiley and Sons

ER -

Bacillus Calmette - Guerin ( BCG ) for Urothelial Carcinoma of the Bladder

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Cite this